EIF2AK1 antibody (AA 37-508)
Quick Overview for EIF2AK1 antibody (AA 37-508) (ABIN7988711)
Target
See all EIF2AK1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- AA 37-508
-
Purpose
- Anti-EIF2AK1 Antibody
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins.
-
Characteristics
- Anti-EIF2AK1 Antibody. Tested in ELISA, Flow Cytometry, IF, IHC, ICC, WB applications. This antibody reacts with Human, Mouse, Rat.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human EIF2AK1 recombinant protein (Position: E37-D508).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western blot, 0.25-0.5 μg/mL, Human, Mouse, Rat Immunohistochemistry(Paraffin-embedded Section), 2-5 μg/mL, Human Immunocytochemistry/Immunofluorescence, 5 μg/mL, Human ELISA, 0.1-0.5 μg/mL, -
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Concentration
- 500 μg/mL
-
Buffer
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing. -
Expiry Date
- 12 months
-
-
- EIF2AK1 (Eukaryotic Translation Initiation Factor 2-alpha Kinase 1 (EIF2AK1))
-
Alternative Name
- EIF2AK1
-
Background
-
Background: Eukaryotic translation initiation factor 2-alpha kinase 1 is an enzyme that in humans is encoded by the EIF2AK1 gene. The protein encoded by this gene acts at the level of translation initiation to downregulate protein synthesis in response to stress. The encoded protein is a kinase that can be inactivated by hemin. Two transcript variants encoding different isoforms have been found for this gene.
Gene Full Name: eukaryotic translation initiation factor 2 alpha kinase 1
-
Molecular Weight
- 71 kDa
-
Gene ID
- 27102
-
UniProt
- Q9BQI3
-
Pathways
- Hepatitis C
Target
-